As Xarelto Lawsuit Plaintiffs Prepare, Bellwether Trials Draw Nearer

June 29, 2016 – – TheProductLawyers.com reports on the progress of the multidistrict litigation (MDL) 2592 against Xarelto and its manufacturers, Bayer AG and Janssen Pharmaceuticals (a division of Johnson & Johnson Corporation.) Late in 2015, the U.S. Judicial Panel on Multidistrict Litigation responded to the petition to combine nearly 3,000 individual suits with similar claims.

In the interest of conserving resources, both public and private, the JPML agreed to proceed. As an additional measure to expedite the trial, they appointed Judge Eldon Fallon to preside over the mass litigation in the Eastern District of Louisiana. Any additional lawsuits with similar claims brought before federal courts are designated to be included in the existing MDL.

There are several allegations leveled at the massive drug manufacturers, many of which are held in common by the plaintiffs. Perhaps the most common is a claim that taking the anticoagulant placed individuals at a substantially increased risk of a catastrophic bleeding event. This is the occurrence of bleeding that cannot be stopped, except in some cases, with immediate and drastic medical intervention.

On December 17th, shortly after the JPML issued its decision, Judge Fallon instructed both parties to select ten cases from the lawsuits of the MDL. These cases must be among the readiest to proceed to trial, and drawn from the states with the most claims. The court then merged the cases with another twenty court-selected lawsuits drawn from Louisiana, Mississippi, and eight other states.

These, Judge Fallon explained, would form a trial pool from which four cases would then be drawn for bellwether proceedings. Commonly used as a measure to further expedite lengthy and complex court cases, bellwether trials allow both the plaintiffs and the defendants to present evidence before a jury panel. They can then observe the reactions, draw conclusions, and tailor their approach in subsequent case hearings.

As plaintiffs await the coming trials of MDL 2592, they are confident that subsequent lawsuits will continue to be joined into the MDL .

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60011091